The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125662101 12566210 1 I 201605 20160705 20160718 20160718 EXP FR-ASTELLAS-2016US026042 ASTELLAS 75.39 YR M Y 0.00000 20160718 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125662101 12566210 1 PS Advagraf TACROLIMUS 1 Oral U 204096 1 MG MODIFIED-RELEASE CAPSULE, HARD TID
125662101 12566210 2 SS CERTICAN EVEROLIMUS 1 Oral 0.5 MG, TWICE DAILY U 0 .5 MG FORMULATION UNKNOWN BID
125662101 12566210 3 SS MYFORTIC MYCOPHENOLATE SODIUM 1 Oral 0 360 MG FORMULATION UNKNOWN BID
125662101 12566210 4 SS CORTANCYL PREDNISONE 1 Oral U 0 5 MG FORMULATION UNKNOWN QD
125662101 12566210 5 C KARDEGIC ASPIRIN LYSINE 1 Oral U 0 75 MG FORMULATION UNKNOWN QD
125662101 12566210 6 C INEXIUM /01479302/ ESOMEPRAZOLE MAGNESIUM 1 Oral U 0 20 MG FORMULATION UNKNOWN QD
125662101 12566210 7 C CARDENSIEL BISOPROLOL FUMARATE 1 Oral U 0 2.5 MG FORMULATION UNKNOWN QD
125662101 12566210 8 C ACTONEL RISEDRONATE SODIUM 1 Oral 35 MG, PER WEEK U 0 35 MG FORMULATION UNKNOWN /wk
125662101 12566210 9 C UVEDOSE CHOLECALCIFEROL 1 Oral 100000 IU, TWICE A MONTH U 0 100000 IU FORMULATION UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125662101 12566210 1 Renal transplant
125662101 12566210 2 Renal transplant
125662101 12566210 3 Product used for unknown indication
125662101 12566210 4 Renal transplant
125662101 12566210 5 Product used for unknown indication
125662101 12566210 6 Product used for unknown indication
125662101 12566210 7 Product used for unknown indication
125662101 12566210 8 Product used for unknown indication
125662101 12566210 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
125662101 12566210 OT
125662101 12566210 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125662101 12566210 Brain abscess
125662101 12566210 Cerebral artery embolism
125662101 12566210 Endocarditis
125662101 12566210 Fall
125662101 12566210 Head injury
125662101 12566210 Inappropriate schedule of drug administration
125662101 12566210 Loss of consciousness
125662101 12566210 Malaise
125662101 12566210 Subdural haematoma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125662101 12566210 2 20160513 0
125662101 12566210 3 20160513 0
125662101 12566210 5 20160525 0